The market is segmented based on , By Category (Antisense, siRNA, miRNA, Aptamer, Decoy, CpG-oilgo), Structure (Single-Stranded DNA/RNA, Double-Stranded DNA, Single-Stranded DNA, Others), Target (Transcriptor Factor, TLR9-Receptor, Protein), Mechanism (Inhibits the Physiological Effect, Adjuvant, Inhibits Transcription, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
.
The Global Nucleic Acid Based Drugs Market size was valued at USD 32.05 USD Million in 2022.
The Global Nucleic Acid Based Drugs Market is projected to grow at a CAGR of 19.8% during the forecast period of 2023 to 2030.
The major players operating in the market include Wave Life Sciences Ltd. Copernicus Therapeutics Inc. , Imugene , PYC Therapeutics , Protagonist Therapeutics Inc. , Benitec Biopharma , EgenInc. , Biomedica Medizinprodukte GmbH , Transgene , Arrowhead PharmaceuticalsInc. , Ionis Pharmaceuticals , Alnylam PharmaceuticalsInc. , ModernaInc. , Gotham Therapeutics , Sumitomo Chemical Co.Ltd. , Eli Lilly and Company .
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.